Is Fractyl Health going out of business?

FRACTYL HEALTH, INC. (GUTS) Fundamentals

A quick summary of the latest filed figures while the full analysis loads.

FRACTYL HEALTH, INC. (GUTS) scores 11 out of 100 on fundamentals, Distressed / Caution, based on SEC filing data.

Leading signal: Shares dilution YoY: 223.93% (YoY)

Five questions, kept separate

Survival - Fragile

5-8 mo of estimated runway from 2026-06-30, based on $47.1M of cash and short-term investments against $90.9M of annual burn. A disclosed filing event caps this reading; Event Risk carries the detail.

Business quality - Pre-commercial

Operating margins cannot grade a pipeline; Survival and clinical evidence remain the relevant lenses here.

Trajectory - Clinical progress unavailable

Fundamentals can show funding and burn, but not whether the clinical pipeline is advancing.

Valuation - Extreme expectations

-10.8% net-cash backing support an extreme expectations pre-commercial Valuation assessment.

Event risk - Critical event risk

Going-Concern Warning is the decisive filing event; one adverse event family is active. It appears across 2 scanned filings. Favorable events are shown separately and do not offset adverse risk.

What the rules read

• Shares dilution YoY: 223.93% (YoY)
• Debt / Equity: Negative equity (balance sheet deficit; monitor solvency)
• Filing event risk: Going-Concern Warning (-8 pts)
• Return on Assets: -171.95%
• Cash Runway (years): 0.52y
• Debt Maturity Runway: 100% long-term (Long-term focused)
• Price / Earnings: Unprofitable (see Valuation)

Read from filings through 2026-08-24.

Price as of 2026-09-07.